Who has invested in AccuVein?

MVM Life Sciences Partners, Bessemer Venture Partners are named among the investors backing AccuVein.

AccuVein Funding: $79M Raised, Growth (2023)

AccuVein funding overview

AccuVein is based in Chicago. AccuVein has raised $79M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Growth announced in February 2023. The round record for AccuVein runs through 2023; nothing later has been disclosed. Investors on record include MVM Life Sciences Partners, Bessemer Venture Partners. 2 distinct backers are named across the disclosed rounds.

AccuVein at a glance

Total raised: $79M
Latest round: Growth
Latest round date: February 2023
Headquarters: Chicago
Notable investors: MVM Life Sciences Partners, Bessemer Venture Partners

Frequently asked about AccuVein funding

How much has AccuVein raised?: AccuVein has raised $79M in total disclosed funding across the rounds on record.
Who has invested in AccuVein?: MVM Life Sciences Partners, Bessemer Venture Partners are named among the investors backing AccuVein.
What was the latest AccuVein funding round?: The most recent disclosed round is a Growth, announced in February 2023.
Where is AccuVein based?: AccuVein is based in Chicago.
When did AccuVein last raise?: The last disclosed AccuVein round closed in February 2023 at Growth.

Every AccuVein figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Chicago at a similar stage.

AccuVein Funding: $79M Raised, Growth (2023)

AccuVein funding overview

AccuVein at a glance

Frequently asked about AccuVein funding

Companies related to AccuVein (18)

Browse related funding lists (4)